| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review Articles |
Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Requests for reprints: Daniel S. Peeper, Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands. Phone: 31-20-512-2002; Fax: 31-20-512-2011; E-mail: d.peeper{at}nki.nl.
Resistance to anoikis ("detachment-induced apoptosis") has been suggested to be a prerequisite for cancer cells to metastasize. In a functional screen for suppressors of anoikis, we identified the neurotrophic receptor TrkB. Upon s.c. inoculation in mice, TrkB-expressing cells formed highly invasive and metastatic tumors. Here, we discuss our findings within the context of the proposed role of TrkB in human malignancies and address the question of its feasibility as a target for cancer therapy.
This article has been cited by other articles:
![]() |
T. R. Geiger and D. S. Peeper Critical Role for TrkB Kinase Function in Anoikis Suppression, Tumorigenesis, and Metastasis Cancer Res., July 1, 2007; 67(13): 6221 - 6229. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lahti, T. Teitz, and D. G. Stupack Does Integrin-Mediated Cell Death Confer Tissue Tropism in Metastasis? Cancer Res., June 15, 2006; 66(12): 5981 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Osada, Y. Tatematsu, Y. Yatabe, Y. Horio, and T. Takahashi ASH1 Gene Is a Specific Therapeutic Target for Lung Cancers with Neuroendocrine Features Cancer Res., December 1, 2005; 65(23): 10680 - 10685. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |